GoodRx Holdings (GDRX) Accounts Payables (2019 - 2026)

GoodRx Holdings' Accounts Payables history runs 8 years deep, the most recent figure standing at $14.5 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 4.8% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at $14.5 million (down 4.8% YoY), while the FY2025 annual figure was $19.4 million, up 37.26% from the prior year.
• Accounts Payables came in at $14.5 million for Q1 2026 at GoodRx Holdings, down from $19.4 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $36.3 million in Q4 2023 to a low of $6.8 million in Q2 2023.
• A 5-year average of $19.2 million and a median of $16.8 million in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables soared 203.13% in 2023 and sank 62.34% in 2024, its largest moves.
• GoodRx Holdings' Accounts Payables stood at $17.7 million in 2022, then surged by 104.89% to $36.3 million in 2023, then sank by 61.02% to $14.1 million in 2024, then soared by 37.26% to $19.4 million in 2025, then fell by 25.15% to $14.5 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $14.5 million, $19.4 million, and $28.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison